EYELID STABILISED DESIGN (ESD) Technology
The ESD Technology harnesses the power of natural
eyelid movements on four stabilisation zones2
(rather than traditional prism-ballast designs which
may be affected by gravity to a greater degree2
) to
ensure that, however active your patient’s day may
be, their vision is clear and stable all day2
- Speed: Quickly orientates and stabilises within minutes of application and realigns naturally with every blink7
- No vertical prism in optic zone
- As easy to fit as the spherical lenses+7
Unbeaten in comfort
- Maintains low coefficient of friction, compared to that of the cornea§
HYDRACLEAR® PLUS technology
- • PVP – an embedded wetting agent throughout the lens mimics mucins to help maintain a stable tear film. In this way, ACUVUE® OASYS may help to reduce dryness symptoms caused by staring at digital screens3,4
HIGH UV Blocking
- Class 1 UV Blocking of >99.9% of UVB, 96.1% of UVA raysα#5
What your patients want to know about ACUVUE® OASYS for ASTIGMATISM
- Unbeatable in comfort according to 27 clinical studies.
- Helps to provide clear, stable vision throughout the day, even with extensive head and eye movements2
- Class 1 UV Blockingα#5 delivers the highest level of UV-A and UV-B protection6
Product Specifications
Lens material
senofilcon A
Lens design
HYDRACLEAR® PLUS Technology EYELID STABILISED DESIGN
Water content
38%
Base curve
8.6mm
Diameter
14.5mm
Power range
Plano to -6.00D: -0.75DC, -1.25DC, -1.75DC Axes 10-180 (10◦ steps) -2.25DC, -2.75DC Axes 70-110 and 20-160 (10◦steps) -6.50D to -9.00D: -0.75DC, -1.25DC Axes 10-180 (10◦ steps) -1.75DC, -2.25DC, -2.75DC Axes 20-160 (10◦ steps) +0.25D to +6.00D: -0.75DC, -1.25DC, -1.75DC Axes 70-110 and 20-160 (10◦ steps)
Centre thickness
0.080mm (-3.00D lens)
Oxygen transmissibility (Dk/t)(boundary and edge corrected)
129x10-9 (-3.00D lens)
Oxygen flux
(% available to cornea)
Oxygen transmissibility
(Dk/t)(boundary and edge
corrected)†
98% (open eye) 95% (closed eye)
Class 2 UV Blocking
>99.9% UVB, 96.1% UVA
Visibility features
Visibility tint
Recommended replacement schedule
Daily use: Replacement every 2 weeks Extended wear: Replacement every 1 week
¥ ACUVUE® 2 does NOT contain PVP. ^ Source Euromonitor International Limited; Eyewear 2023 edition; value sales at rsp, all retail channels, 2021 data. * Vertical heterophoria possibly caused by prism dissociation due to the presence of induced optical prism is a relevant factor for practitioners to consider when fitting toric contact lenses for monocular astigmats or those requiring a mix of toric soft contact lens designs.9,10 Clinical studies have not been done to fully characterize the clinical effects of differences in base down prism among different contact lenses. ** Based on high fit success rates, number of lenses required, and time to fit lenses during ACUVUE® Brand for ASTIGMATISM clinical studies. + ClinicalTrials.gov is a website maintained by the NIH. The 27 clinical studies evaluated subjective comfort as a primary or secondary endpoint for ACUVUE® OASYS Brand 2-week family, ACUVUE® OASYS 1-Day Brand family, and ACUVUE® OASYS MAX 1-Day Brand family of contact lenses, vs. competitors’ products. Review conducted as of October 31, 2022. § Using t-test on least-square means from the linear mixed model. Adjusted for multiplicity. JJV Data on File 2020. α All ACUVUE® contact lenses have Class 1 or Class 2 UV Blocking to help provide protection against transmission of harmful UV radiation to the cornea and into the eye. UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. UV transmission measured with -1.00 lens. # Helps protect against transmission of harmful UV radiation to the cornea and into the eye. † Oxygen transmissibility at centre of a -3.00D lens using boundary-corrected, edge-corrected Dk values. Units: (cm/sec) (ml O2/ml x mm Hg) at 35oC. Dk determined via polarographic method. ‡ www.clinicaltrials.gov is a website maintained by the NIH. Since February 2007, 27 clinical studies evaluated subjective comfort as a primary or secondary endpoint for ACUVUE® OASYS Brand families of contact lenses vs. competitors’ products. Review conducted as of October 31, 2022. 1. JJV Data on File 2020. ACUVUE® Brand - EYE-INSPIRED™ INNOVATIONS. 2. JJV Data on File 2021. ACUVUE® Brand Contact Lenses for ASTIGMATISM - Overall Fitting Success, Orientation Position, Rotational Stability, and Vision Performance. 3. JJV Data on File 2017. A 4-week randomized, masked, controlled, cross-over, dispensing daily wear study with ACUVUE® OASYS vs. ULTRA; n=127 subjects who spent greater than or equal to 8 hours per day using digital devices during the study period. 4. JJV Data on File 2018. Similarities between Mucin and Poly(N-Vinyl Pyrrolidone) (PVP). 5. JJV Data on File 2019. Material Properties for Reusable Toric Contact Lenses, Including ACUVUE® OASYS Brand Contact Lenses for ASTIGMATISM and ACUVUE® VITA® Brand Contact Lenses for ASTIGMATISM. 6. JJV Data on File 2017. ACUVUE® Brand Reusable Spherical Contact Lenses vs widely prescribed conventional contact lenses in Korea